Granted Patent
B2
US 8,501,944 · App. 13/360,862 · Granted Aug 6, 2013
Inhibitors of protein kinases
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention is directed to a compound of the formula: and pharmaceutically acceptable tautomers, or salts thereof which are inhibitors of syk and/or JAK kinase. The present invention is also directed to pharmaceutical compositions containing such a compound.
Claims (3)
1. A compound, having the structure:
or a pharmaceutically acceptable salt thereof.
2. A composition comprising a compound of claim 1 , in combination with a pharmaceutically acceptable carrier or diluent.
Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 14, 2021
From: PORTOLA PHARMACEUTICALS, LLC
To: ALEXION PHARMACEUTICALS, INC.
Reel/Frame 054999/0218 →
CHANGE OF NAME
Recorded Jan 12, 2021
From: PORTOLA PHARMACEUTICALS, INC.
To: PORTOLA PHARMACEUTICALS, LLC
Reel/Frame 054975/0183 →
RELEASE OF SECURITY INTEREST
Recorded Jul 2, 2020
From: HCR COLLATERAL MANAGEMENT, LLC
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 053120/0925 →
SECURITY INTEREST
Recorded Mar 18, 2019
From: PORTOLA PHARMACEUTICALS, INC.
To: HCR COLLATERAL MANAGEMENT, LLC
Reel/Frame 048633/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 14, 2015
From: BAUER, SHAWN M.; JIA, ZHAOZHONG J.; SONG, YONGHONG; XU, QING; MEHROTRA, MUKUND; ROSE, JACK W.; HUANG, WOLIN; VENKATARAMANI, CHANDRASEKAR; PANDEY, ANJALI
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 035405/0842 →